Table 3.
Effects of FHH3-associated AP2S1 mutation (Arg15Cys) on CaSR cell-surface expression.
Total CaSR |
Cell-surface CaSR |
|||
---|---|---|---|---|
0.5mM Ca2+ | 5mM Ca2+ | 0.5mM Ca2+ | 5mM Ca2+ | |
Vector | 100±1.4 | 101.9±2.3 | 100±4.9 | 47.1±3.6a* |
WT (Arg15) | 99.3±2.8 | 104.6±0.9 | 93±4.2 | 28.1±2.0b*,d*,e# |
Mutant (Cys15) |
92.6±1.3 | 98.6±2.3 | 98.1±2.8 | 47.1±6.3c* |
HEK293 cells which stably expressed the CaSR were transfected with WT (Arg15) AP2S1, mutant (Cys15) AP2S1 or vector-only constructs, treated with either 0.5mM Ca2+o or 5.0mM Ca2+o for 15 minutes, and cell-surface and total expression of CaSR measured using an intact cell ELISA18. Results were normalised to vector-only transfected cells, as previously reported18, and shown as mean±SEM (n=6) for each experiment. Comparison of total CaSR at 0.5mM and 5mM revealed no significant difference. Comparison of cell-surface CaSR expression revealed significant differences as follows:
Compared to Vector (0.5mM);
Compared to WT (0.5mM);
Compared to Mutant (0.5mM);
Compared to Vector (5mM);
Compared to Mutant (5mM).
p<0.005,
p<0.05.